Mucosally induced immunoglobulin E-associated inflammation in the respiratory tract

Infection and Immunity

Volumn 68, Issue 2, 2000, Pages 672-679

  Simecka, Jerry W ^a   Jackson, Raymond J ^b   Kiyono, Hiroshi ^b,c   McGhee, Jerry R ^b  

^a UNIVERSITY OF NORTH TEXAS HEALTH SCIENCE CENTER   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c OSAKA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLERA TOXIN; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; INTERLEUKIN 5; TETANUS TOXOID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; FEMALE; HISTOPATHOLOGY; IMMUNIZATION; IMMUNOGLOBULIN PRODUCTION; IMMUNOPATHOGENESIS; INFLAMMATION; MOUSE; MUCOSAL IMMUNITY; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY EPITHELIUM; T LYMPHOCYTE ACTIVATION;

ADMINISTRATION, INTRANASAL; ANIMALS; ANTIBODIES, BACTERIAL; CHOLERA TOXIN; FEMALE; IMMUNITY, MUCOSAL; IMMUNIZATION; IMMUNOGLOBULIN E; INFLAMMATION; INTERLEUKIN-5; LUNG; MICE; MICE, INBRED BALB C; TETANUS TOXOID;

EID: 0033983324     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.68.2.672-679.2000     Document Type: Article

References (37)

1. Belshe, R. B., P. M. Mendelman, J. Treanor, J. King, W. C. Gruber, P. Piedra, D. I. Bernstein, F. G. Hayden, K. Kotloff, K. Zangwill, D. lacuzio, and M. Wolff. 1998. The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine in children. N. Engl. J. Med. 338:1405-1412.
2. Blythe, S., D. England, B. Esser, P. Junk, and R. F. Lemanske, Jr. 1986. IgE antibody mediated inflammation of rat lung: histologic and bronchoalveolar lavage assessment. Am. Rev. Respir. Dis. 134:1246-1251.
3. Brandtzaeg, P., G. Karlsson, G. Hansson, B. Petruson, J. Bjorkander, and L. A. Hanson. 1987. The clinical condition of IgA-deficient patients is related to the proportion of IgD- and IgM-producing cells in their nasal mucosa. Clin. Exp. Immunol. 67:626-636.
4. Calvo, M., K. Grob, F. Marin, J. Bertoglio, J. Neira, P. Arellano, and M. Anido. 1988. Evaluation of secretory IgA childhood respiratory diseases. Allergol. Immunopathol. 16:157-161.
5. Casterline, C. L., R. Evans III, V. C. Battista, and R. C. Talamo. 1978. Selective IgA deficiency and Pi ZZ-antitrypsin deficiency. Association with recurrent sinopulmonary infections, emphysema, and bronchiectasis. Chest 73:885-886.
6. Clements, M. L. 1992. Influenza vaccines. Bio/Technology 20:129-150.
7. Clements, M. L., R. F. Betts, E. L. Tierney, and B. R. Murphy. 1986. Serum and nasal wash antibodies associated with resistance to experimental challenge with influenza A wild-type virus. J. Clin. Microbiol. 24:157-160.
8. Clements, M. L., S. O'Donnell, M. M. Levine, R. M. Chanock, and B. R. Murphy. 1983. Dose response of A/Alaska/6/77 (H3N2) cold-adapted reassortment vaccine virus in adult volunteers: role of local antibody in resistance to infection with vaccine virus. Infect. Immun. 40:1044-1051.
9. Doepel, L. 29 January 1998. Novel concepts put to the test in three new AIDS vaccine trials. NIAID News.
10. Finkelman, F. D., J. F. Urban, Jr., M. P. Beckmann, K. A. Schooley, J. M. Holmes, and I. M. Katona. 1991. Regulation of murine in vivo IgG and IgE responses by a monoclonal anti-IL-4 receptor antibody. Int. Immunol. 3:599-607.
11. Graham, B. S., G. S. Henderson, Y. W. Tang, X. Lu, K. M. Neuzil, and D. G. Colley. 1993. Priming immunization determines T helper cytokine mRNA expression patterns in lungs of mice challenged with respiratory syncytial virus. J. Immunol. 151:2032-2040.
12. Graham, M. B., V. L. Braciale, and T. J. Braciale. 1994. Influenza virus-specific CD4+ T helper type 2 T lymphocytes do not promote recovery from experimental virus infection. J. Exp. Med. 180:1273-1282.
13. Gruber, W. C., P. M. Darden, J. G. Still, J. Lohr, G. Reed, and P. F. Wright. 1997. Evaluation of bivalent live attenuated influenza A vaccines in children 2 months to 3 years of age: safety, immunogenicity and dose-response. Vaccine 15:1379-1384.
14. Haas, L., M. Petit-Phar, H. Terzidis, N. Kapel, D. Meillet, J. G. Gobert, and G. Rostoker. 1995. IgA subclass distribution of IgA anti-gliadin antibodies in feces of patients with coeliac disease. Adv. Exp. Med. Biol. 371B:1349-1353.
15. Hbabi-Haddioui, L., and C. Roques. 1997. Inhibition of Streptococcus pneumoniae adhesion by specific salivary IgA after oral immunisation with a ribosomal immunostimulant. Drugs 54:29-32.
16. Jackson, R. J., K. Fujihashi, J. Xu-Amano, H. Kiyono, C. O. Elson, and J. R. McGhee. 1993. Optimizing oral vaccines: induction of systemic and mucosal B-cell and antibody responses to tetanus toxoid by use of cholera toxin as an adjuvant. Infect. Immun. 61:4272-4279.
17. Kurono, Y., K. Shimamura, H. Shigemi, and G. Mogi. 1991. Inhibition of bacterial adherence by nasopharyngeal secretions. Ann. Otol. Rhinol. Laryngol. 100:455-458.
18. Liang, S. C., J. W. Simecka, J. R. Lindsey, G. H. Cassell, and J. K. Davis. 1999. Antibody responses after Sendai virus infection and their role in upper and lower respiratory tract disease in rats. Lab. Anim. Sci. 49:385-394.
19. Liang, X. P., M. E. Lamm, and J. G. Nedrud. 1989. Cholera toxin as a mucosal adjuvant for respiratory antibody responses in mice. Reg. Immunol. 2:244-248.
20. Marinaro, M., H. F. Staats, T. Hiroi, R. J. Jackson, M. Coste, P. N. Boyaka, N. Okahashi, M. Yamamoto, H. Kiyono, H. Bluethmann, et al. 1995. Mucosal adjuvant effect of cholera toxin in mice results from induction of T helper 2 (Th2) cells and IL-4. J. Immunol. 155:4621-4629.
21. Mosmann, T., and R. Coffman. 1989. TH1 and TH2: different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol. 7:145-173.
22. Murphy, B. R., M. L. Clements, P. R. Johnson, and P. F. Wright 1988. The mucosal and systemic immune responses of children and adults to live and inactivated influenza A virus vaccines, p. 303. In W. Strober, M. E. Lamm, J. R. McGhee, and S. P. James (ed.), Mucosal immunity and infections at mucosal surfaces. Oxford University Press, New York, N.Y.
23. Novak, M., Z. Moldoveanu, D. P. Schafer, J. Mestecky, and R. W. Compans. 1993. Murine model for evaluation of protective immunity to influenza virus. Vaccine 11:55-60.
24. + Th2 cells producing IL-6 and IL-10 are associated with mucosal immunoglobulin A responses. Infect. Immun. 64:1516-1525.
25. Ostergaard, P. A. 1977. IgA levels, bacterial carrier rate, and the development of bronchial asthma in children. Acta Pathol. Microbiol. Scand. Sect. C 85:187-195.
26. Renegar, K. B., and P. A. Small, Jr. 1991. Immunoglobulin A mediation of murine nasal anti-influenza virus immunity. J. Virol. 65:2146-2148.
27. Renegar, K. B., and P. A. Small, Jr. 1991. Passive transfer of local immunity to influenza virus infection by IgA antibody. J. Immunol. 146:1972-1978.
28. Reuman, P. D., S. P. Keely, and G. M. Schiff. 1991. Similar subclass antibody responses after intranasal immunization with UV-inactivated RSV mixed with cholera toxin or live RSV. J. Med. Virol. 35:192-197.
29. Robinson, D. S., S. R. Durham, and A. B. Kay. 1993. Cytokines. 3. Cytokines in asthma. Thorax 48:845-853.
30. Small, P. A., Jr. 1990. Influenza: pathogenesis and host defense. Hosp. Pract. 25:51-54, 57-62.
31. Snider, D. P., J. S. Marshall, M. H. Perdue, and H. Liang. 1994. Production of IgE antibody and allergic sensitization of intestinal and peripheral tissues after oral immunization with protein antigen and cholera toxin. J. Immunol. 153:647-657.
32. Tamura, S., Y. Ito, H. Asanuma, Y. Hirabayashi, Y. Suzuki, T. Nagamine, C. Aizawa, and T. Kurata. 1992. Cross-protection against influenza virus infection afforded by trivalent inactivated vaccines inoculated intranasally with cholera toxin B subunit. J. Immunol. 149:981-988.
33. Tamura, S. I., H. Asamima, Y. Ito, Y. Hirabayashi, Y. Suzuki, T. Nagamine, C. Aizawa, T. Kurata, and A. Oya. 1992. Superior cross-protective effect of nasal vaccination to subcutaneous inoculation with influenza hemagglutinin vaccine. Eur. J. Immunol. 22:477-481.
34. Taylor, G., and C. J. Howard. 1981. Protection of mice against Mycoplasma pulmonis infection using purified mouse immunoglobulins: comparison between protective effect and biological properties of immunoglobulin classes. Immunology 43:519-525.
35. van Ginkel, F. W., C. Liu, J. W. Simecka, J. Y. Dong, T. Greenway, R. A. Frizzell, H. Kiyono, J. R. McGhee, and D. W. Pascual. 1995. Intratracheal gene delivery with adenoviral vector induces elevated systemic IgG and mucosal IgA antibodies to adenovirus and beta-galactosidase. Hum. Gene Ther. 6:895-903.
36. Wallace, W. A., E. A. Ramage, D. Lamb, and S. E. Howie. 1995. A type 2 (Th2-like) pattern of immune response predominates in the pulmonary interstitium of patients with cryptogenic fibrosing alveolitis (CFA). Clin. Exp. Immunol. 101:436-441.
37. Walsh, E. E. 1993. Mucosal immunization with a subunit respiratory syncytial virus vaccine in mice. Vaccine 11:1135-1138.